MUC5B Promoter Polymorphism and Development of Acute Respiratory Distress Syndrome

doi:10.1164/rccm.201801-0140LE

Observational Study

. 2018 Nov 15;198(10):1342-1345.

doi: 10.1164/rccm.201801-0140LE.

MUC5B Promoter Polymorphism and Development of Acute Respiratory Distress Syndrome

Affiliations

¹ 1 Stanford University Stanford, California.
² 2 Vanderbilt University Nashville, Tennessee.
³ 3 Brigham and Women's Hospital Boston, Massachusetts.
⁴ 4 University of Pennsylvania Perelman School of Medicine Philadelphia, Pennsylvania.
⁵ 5 Louisiana State University School of Medicine New Orleans, Louisiana.
⁶ 6 University of Colorado Aurora, Colorado and.
⁷ 7 Department of Veterans Affairs Medical Center Nashville, Tennessee.

PMID: 30025215
PMCID: PMC6290941
DOI: 10.1164/rccm.201801-0140LE

Observational Study

MUC5B Promoter Polymorphism and Development of Acute Respiratory Distress Syndrome

Angela J Rogers et al. Am J Respir Crit Care Med. 2018.

. 2018 Nov 15;198(10):1342-1345.

doi: 10.1164/rccm.201801-0140LE.

Authors

Affiliations

¹ 1 Stanford University Stanford, California.
² 2 Vanderbilt University Nashville, Tennessee.
³ 3 Brigham and Women's Hospital Boston, Massachusetts.
⁴ 4 University of Pennsylvania Perelman School of Medicine Philadelphia, Pennsylvania.
⁵ 5 Louisiana State University School of Medicine New Orleans, Louisiana.
⁶ 6 University of Colorado Aurora, Colorado and.
⁷ 7 Department of Veterans Affairs Medical Center Nashville, Tennessee.

PMID: 30025215
PMCID: PMC6290941
DOI: 10.1164/rccm.201801-0140LE

No abstract available

PubMed Disclaimer

Cited by

Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19.
Kiener M, Roldan N, Machahua C, Sengupta A, Geiser T, Guenat OT, Funke-Chambour M, Hobi N, Kruithof-de Julio M. Kiener M, et al. Front Med (Lausanne). 2021 May 7;8:644678. doi: 10.3389/fmed.2021.644678. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34026781 Free PMC article. Review.
From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
Michalski JE, Kurche JS, Schwartz DA. Michalski JE, et al. Transl Res. 2022 Mar;241:13-24. doi: 10.1016/j.trsl.2021.09.001. Epub 2021 Sep 20. Transl Res. 2022. PMID: 34547499 Free PMC article. Review.
Influence of SARS-CoV-2 on airway mucus production: A review and proposed model.
Meyerholz DK, Reznikov LR. Meyerholz DK, et al. Vet Pathol. 2022 Jul;59(4):578-585. doi: 10.1177/03009858211058837. Epub 2021 Nov 18. Vet Pathol. 2022. PMID: 34794359 Free PMC article. Review.
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH 3rd, Kato T, Lee RE, Yount BL, Mascenik TM, Chen G, Olivier KN, Ghio A, Tse LV, Leist SR, Gralinski LE, Schäfer A, Dang H, Gilmore R, Nakano S, Sun L, Fulcher ML, Livraghi-Butrico A, Nicely NI, Cameron M, Cameron C, Kelvin DJ, de Silva A, Margolis DM, Markmann A, Bartelt L, Zumwalt R, Martinez FJ, Salvatore SP, Borczuk A, Tata PR, Sontake V, Kimple A, Jaspers I, O'Neal WK, Randell SH, Boucher RC, Baric RS. Hou YJ, et al. Cell. 2020 Jul 23;182(2):429-446.e14. doi: 10.1016/j.cell.2020.05.042. Epub 2020 May 27. Cell. 2020. PMID: 32526206 Free PMC article.
Genomics and the Acute Respiratory Distress Syndrome: Current and Future Directions.
Hernández-Beeftink T, Guillen-Guio B, Villar J, Flores C. Hernández-Beeftink T, et al. Int J Mol Sci. 2019 Aug 16;20(16):4004. doi: 10.3390/ijms20164004. Int J Mol Sci. 2019. PMID: 31426444 Free PMC article. Review.

See all "Cited by" articles

References

1. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med. 2011;364:1503–1512. - PMC - PubMed
1. Hunninghake GM, Hatabu H, Okajima Y, Gao W, Dupuis J, Latourelle JC, et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med. 2013;368:2192–2200. - PMC - PubMed
1. Putman RK, Hunninghake GM, Dieffenbach PB, Barragan-Bradford D, Serhan K, Adams U, et al. Interstitial lung abnormalities are associated with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017;195:138–141. - PMC - PubMed
1. Ware LB, Koyama T, Zhao Z, Janz DR, Wickersham N, Bernard GR, et al. Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care. 2013;17:R253. - PMC - PubMed
1. O’Neal HR, Jr, Koyama T, Koehler EA, Siew E, Curtis BR, Fremont RD, et al. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2011;39:1343–1350. - PMC - PubMed

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med. 2011;364:1503–1512. - PMC - PubMed

[2] Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med. 2011;364:1503–1512. - PMC - PubMed

[3] Hunninghake GM, Hatabu H, Okajima Y, Gao W, Dupuis J, Latourelle JC, et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med. 2013;368:2192–2200. - PMC - PubMed

[4] Hunninghake GM, Hatabu H, Okajima Y, Gao W, Dupuis J, Latourelle JC, et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med. 2013;368:2192–2200. - PMC - PubMed

[5] Putman RK, Hunninghake GM, Dieffenbach PB, Barragan-Bradford D, Serhan K, Adams U, et al. Interstitial lung abnormalities are associated with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017;195:138–141. - PMC - PubMed

[6] Putman RK, Hunninghake GM, Dieffenbach PB, Barragan-Bradford D, Serhan K, Adams U, et al. Interstitial lung abnormalities are associated with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017;195:138–141. - PMC - PubMed

[7] Ware LB, Koyama T, Zhao Z, Janz DR, Wickersham N, Bernard GR, et al. Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care. 2013;17:R253. - PMC - PubMed

[8] Ware LB, Koyama T, Zhao Z, Janz DR, Wickersham N, Bernard GR, et al. Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care. 2013;17:R253. - PMC - PubMed

[9] O’Neal HR, Jr, Koyama T, Koehler EA, Siew E, Curtis BR, Fremont RD, et al. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2011;39:1343–1350. - PMC - PubMed

[10] O’Neal HR, Jr, Koyama T, Koehler EA, Siew E, Curtis BR, Fremont RD, et al. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2011;39:1343–1350. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

MUC5B Promoter Polymorphism and Development of Acute Respiratory Distress Syndrome

Affiliations

MUC5B Promoter Polymorphism and Development of Acute Respiratory Distress Syndrome

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources